These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 15231735)

  • 41. Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins.
    Nellist M; Goedbloed MA; Halley DJ
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):587-91. PubMed ID: 12773161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity.
    Hahn-Windgassen A; Nogueira V; Chen CC; Skeen JE; Sonenberg N; Hay N
    J Biol Chem; 2005 Sep; 280(37):32081-9. PubMed ID: 16027121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. c-myc Repression of TSC2 contributes to control of translation initiation and Myc-induced transformation.
    Ravitz MJ; Chen L; Lynch M; Schmidt EV
    Cancer Res; 2007 Dec; 67(23):11209-17. PubMed ID: 18056446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor.
    Liu JL; Mao Z; Gallick GE; Yung WK
    Neuro Oncol; 2011 Feb; 13(2):184-94. PubMed ID: 21123367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.
    Inoki K; Li Y; Xu T; Guan KL
    Genes Dev; 2003 Aug; 17(15):1829-34. PubMed ID: 12869586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling.
    van Veelen W; Korsse SE; van de Laar L; Peppelenbosch MP
    Oncogene; 2011 May; 30(20):2289-303. PubMed ID: 21258412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1.
    Distefano G; Boca M; Rowe I; Wodarczyk C; Ma L; Piontek KB; Germino GG; Pandolfi PP; Boletta A
    Mol Cell Biol; 2009 May; 29(9):2359-71. PubMed ID: 19255143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo.
    Collins SP; Reoma JL; Gamm DM; Uhler MD
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):673-80. PubMed ID: 10642527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity.
    Xie J; Ponuwei GA; Moore CE; Willars GB; Tee AR; Herbert TP
    Cell Signal; 2011 Dec; 23(12):1927-35. PubMed ID: 21763421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LIP1, a cytoplasmic protein functionally linked to the Peutz-Jeghers syndrome kinase LKB1.
    Smith DP; Rayter SI; Niederlander C; Spicer J; Jones CM; Ashworth A
    Hum Mol Genet; 2001 Dec; 10(25):2869-77. PubMed ID: 11741830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dysregulation of the TSC-mTOR pathway in human disease.
    Inoki K; Corradetti MN; Guan KL
    Nat Genet; 2005 Jan; 37(1):19-24. PubMed ID: 15624019
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1.
    Di Nardo A; Wertz MH; Kwiatkowski E; Tsai PT; Leech JD; Greene-Colozzi E; Goto J; Dilsiz P; Talos DM; Clish CB; Kwiatkowski DJ; Sahin M
    Hum Mol Genet; 2014 Jul; 23(14):3865-74. PubMed ID: 24599401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model.
    Wei C; Amos CI; Zhang N; Zhu J; Wang X; Frazier ML
    Cancer Lett; 2009 May; 277(2):149-54. PubMed ID: 19147279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
    Shaw RJ
    Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling.
    Lin-Marq N; Borel C; Antonarakis SE
    Mol Genet Genomics; 2005 Apr; 273(2):184-96. PubMed ID: 15731909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wnt signaling may be activated in a subset of Peutz-Jeghers syndrome polyps closely correlating to LKB1 expression.
    Ma Y; Zhang G; Fu X; Xia O; Zhan C; Li L; Wang Z; Wu B
    Oncol Rep; 2010 Jun; 23(6):1569-76. PubMed ID: 20428811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death.
    Karuman P; Gozani O; Odze RD; Zhou XC; Zhu H; Shaw R; Brien TP; Bozzuto CD; Ooi D; Cantley LC; Yuan J
    Mol Cell; 2001 Jun; 7(6):1307-19. PubMed ID: 11430832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian Target of Rapamycin Complex 1.
    Tanwar PS; Kaneko-Tarui T; Zhang L; Tanaka Y; Crum CP; Teixeira JM
    PLoS Genet; 2012; 8(8):e1002906. PubMed ID: 22916036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tuberous sclerosis-2 (TSC2) regulates the stability of death-associated protein kinase-1 (DAPK) through a lysosome-dependent degradation pathway.
    Lin Y; Henderson P; Pettersson S; Satsangi J; Hupp T; Stevens C
    FEBS J; 2011 Jan; 278(2):354-70. PubMed ID: 21134130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.